Valuation: Codexis, Inc.

Market Cap 13Cr 12Cr 11Cr 9.91Cr 19Cr 1.26TCr 19Cr 130.63Cr 52Cr 660.36Cr 50Cr 49Cr 2.09TCr P/E 2026 *
-3.18x
P/E 2027 * -4.15x
Enterprise Value 13Cr 12Cr 11Cr 9.91Cr 19Cr 1.26TCr 19Cr 130.63Cr 52Cr 660.36Cr 50Cr 49Cr 2.09TCr EV / Sales 2026 *
1.79x
EV / Sales 2027 * 1.51x
Free-Float
92.89%
Yield 2026 *
-
Yield 2027 * -
1 day-3.17%
1 week-5.43%
Current month-12.23%
1 month-10.29%
3 months-18.67%
6 months-56.74%
Current year-25.15%
1 week 1.2
Extreme 1.2
1.33
1 month 1.2
Extreme 1.2
1.44
Current year 0.96
Extreme 0.9583
2.98
1 year 0.96
Extreme 0.9583
2.98
3 years 0.96
Extreme 0.9583
6.08
5 years 0.96
Extreme 0.9583
42.01
10 years 0.96
Extreme 0.9583
42.01
Manager TitleAgeSince
Chief Executive Officer 59 07/11/2025
Director of Finance/CFO 59 30/09/2024
Chief Tech/Sci/R&D Officer 56 05/05/2020
Director TitleAgeSince
Director/Board Member 66 01/03/2016
Director/Board Member 59 07/11/2025
Chairman 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
12/10/26 Sell

Chief Financial Officer

-6,335 0.0058%
12/10/26 Sell

Chief Executive Officer

-6,335 0.0058%
23/02/26 Free

Chief Financial Officer

3,16,100 0.3500%
Change 5-day change 1-year change 3-year change Capi.($)
-3.17%-5.43%-52.90%-21.29% 14Cr
+0.34%-3.03%+37.45%+61.06% 6.41TCr
+0.98%+2.26%+12.91%+82.98% 5.55TCr
+1.75%+2.76%+12.38%+103.69% 5.3TCr
-1.43%-0.57%+26.10%+52.86% 4.6TCr
-0.48%-3.86%+17.27%+117.99% 4.25TCr
+0.82%-2.06%+227.09%+922.41% 4.04TCr
-0.26%-4.20%+10.86%+45.18% 3.23TCr
-2.07%+44.58%+102.84%+88.74% 3.45TCr
-2.72%-8.79%+22.58%-5.63% 2.42TCr
Average -0.65%+3.21%+41.66%+144.80% 3.93TCr
Weighted average by Cap. -0.11%+3.13%+49.23%+160.82%

Financials

2026 *2027 *
Net sales 7.39Cr 6.62Cr 6.11Cr 5.52Cr 10Cr 703.57Cr 10Cr 73Cr 29Cr 368.22Cr 28Cr 27Cr 1.17TCr 8.77Cr 7.85Cr 7.25Cr 6.56Cr 12Cr 835.04Cr 12Cr 86Cr 34Cr 437.02Cr 33Cr 32Cr 1.38TCr
Net income -3.72Cr -3.33Cr -3.07Cr -2.78Cr -5.2Cr -354.12Cr -5.28Cr -37Cr -15Cr -185.33Cr -14Cr -14Cr -586.98Cr -2.97Cr -2.66Cr -2.45Cr -2.22Cr -4.15Cr -282.56Cr -4.22Cr -29Cr -12Cr -147.88Cr -11Cr -11Cr -468.36Cr
Net Debt - -
Projected Income Statement - Annual - Codexis, Inc.
Logo Codexis, Inc.
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Employees
146
Date Price Change Volume
30/26/30 $1.220 -3.17% 9,15,861
28/26/28 $1.260 -1.56% 16,45,786
27/26/27 $1.280 -1.54% 6,91,460
26/26/26 $1.300 +1.56% 3,92,376
23/26/23 $1.280 -2.29% 5,46,625
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Codexis, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1.210USD
Average target price
6.143USD
Spread / Average Target
+407.67%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Codexis, Inc.
  1. Stock Market
  2. Stocks
  3. CDXS Stock